Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ELMD Stock Forecast 2026-2027
$42.10
Current Price
$350.16M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ELMD Price Targets
+6.9%
To High Target of $45.00
-5.0%
To Median Target of $40.00
-14.5%
To Low Target of $36.00
ELMD Price Momentum
-7.8%
1 Week Change
+8.8%
1 Month Change
+130.9%
1 Year Change
+44.6%
Year-to-Date Change
-11.2%
From 52W High of $47.40
+137.5%
From 52W Low of $17.73
📊 TOP ANALYST CALLS
Did ELMD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Electromed is one of their latest high-conviction picks.
Latest ELMD Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, ELMD has a bullish consensus with a median price target of $40.00 (ranging from $36.00 to $45.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $42.10, the median forecast implies a -5.0% downside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Benjamin Haynor at Lake Street, suggesting a 14.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ELMD Analyst Ratings
3
Buy
0
Hold
0
Sell
ELMD Price Target Range
Low
$36.00
Average
$40.00
High
$45.00
Current: $42.10
Latest ELMD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ELMD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 13, 2026 | B. Riley Securities | Buy | Maintains | $N/A | |
| Feb 12, 2026 | Freedom Broker | Buy | Maintains | $N/A | |
| Nov 19, 2025 | Freedom Broker | Buy | Maintains | $N/A | |
| Nov 13, 2025 | Roth Capital | Buy | Reiterates | $N/A | |
| Aug 27, 2025 | Roth Capital | Buy | Maintains | $N/A | |
| Aug 27, 2025 | Lake Street | Benjamin Haynor | Buy | Assumes | $36.00 |
| Jul 22, 2025 | Roth Capital | Buy | Initiates | $N/A | |
| Feb 20, 2025 | B. Riley Securities | Buy | Initiates | $N/A | |
| May 11, 2023 | EF Hutton | Buy | Reiterates | $N/A | |
| Feb 16, 2023 | EF Hutton | Buy | Maintains | $N/A | |
| Feb 15, 2023 | Lake Street | Buy | Maintains | $N/A | |
| Dec 28, 2022 | Lake Street | Brooks O'Neil | Buy | Assumes | $20.00 |
| Sep 6, 2022 | EF Hutton | Buy | Initiates | $N/A | |
| Aug 5, 2022 | Lake Street | Buy | Initiates | $N/A | |
| Nov 24, 2020 | Northland Capital Markets | Outperform | Initiates | $N/A | |
| Oct 18, 2019 | Dougherty & Co. | Buy | Initiates | $N/A |
Electromed Inc. (ELMD) Competitors
The following stocks are similar to Electromed based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Electromed Inc. (ELMD) Financial Data
Electromed Inc. has a market capitalization of $350.16M with a P/E ratio of 37.7x. The company generates $71.75M in trailing twelve-month revenue with a 14.1% profit margin.
Revenue growth is +18.4% quarter-over-quarter, while maintaining an operating margin of +20.3% and return on equity of +21.7%.
Valuation Metrics
Market Cap
$350.16M
Enterprise Value
$363.90M
P/E Ratio
37.7x
PEG Ratio
0.6x
Price/Sales
5.1x
Growth & Margins
Revenue Growth (YoY)
+18.4%
Gross Margin
+78.8%
Operating Margin
+20.3%
Net Margin
+14.1%
EPS Growth
+58.8%
Financial Health
Cash/Price Ratio
+4.9%
Current Ratio
4.9x
Debt/Equity
0.2x
ROE
+21.7%
ROA
+14.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Electromed Inc. (ELMD) Business Model
About Electromed Inc.
What They Do
Manufactures medical devices for respiratory therapy.
Business Model
The company generates revenue by designing, manufacturing, and distributing innovative medical devices that focus on respiratory therapy solutions. It primarily sells products like the SmartVest Airway Clearance System to healthcare providers and patients, targeting individuals with chronic respiratory conditions such as cystic fibrosis and bronchiectasis.
Additional Information
Electromed Inc. is committed to research and development, which helps it stay competitive in the healthcare market. The company aims to expand the accessibility of its products through strategic partnerships and networks, enhancing its market influence in the respiratory care segment.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
177
CEO
Mr. James L. Cunniff
Country
United States
IPO Year
2010
Website
smartvest.comElectromed Inc. (ELMD) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.
Jul 10, 2026
By Nilanjan Banerjee
Analyst Blog
Latest News
Quick Summary
LQDA, FLXS, ELMD, and AGX show low beta, positive price momentum, and strong fundamentals, potentially aiding investors in managing market volatility.
Why It Matters
Low beta stocks like LQDA, FLXS, ELMD, and AGX offer stability during market fluctuations, while strong fundamentals and positive momentum can lead to potential growth opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Electromed (ELMD) has passed the "Recent Price Strength" screen, indicating it may be a strong investment option for those seeking stocks with upward momentum.
Why It Matters
Electromed's recent price strength indicates positive momentum, suggesting potential for profit, which may attract investors seeking growth opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Electromed (ELMD) is identified as a strong stock candidate, having passed the "Recent Price Strength" screen, indicating potential for continued upward momentum.
Why It Matters
Electromed (ELMD) shows strong price momentum, indicating potential for continued growth, making it an attractive option for investors seeking upward-trending stocks.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Electromed is rated 'buy' due to strong growth and margins. Q3 FY 2026 net income reached $3M, with gross margin at 78.5% and operating margin at 20.4%. A new CMS rule and drug approval boost market potential.
Why It Matters
Electromed's strong growth, improved margins, and a favorable market position enhance its investment attractiveness, signaling potential for continued profitability and market expansion.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Electromed (ELMD) is expected to outperform the market due to its above-average growth in financials.
Why It Matters
Electromed's above-average financial growth suggests potential for strong returns, indicating it may outperform market peers, attracting investor interest and driving stock demand.
Source: Zacks Investment Research
Market Sentiment:
Positive
New Strong Buy Stocks for June 2nd
1 month ago
Quick Summary
GOLD, ELMD, TPR, PLGO, and CRGY have been assigned a Zacks Rank #1 (Strong Buy) as of June 2, 2026.
Why It Matters
The addition of GOLD, ELMD, TPR, PLGO, and CRGY to the Zacks Rank #1 (Strong Buy) List signals strong growth potential, indicating favorable investment opportunities in these stocks.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About ELMD Stock
What is Electromed Inc.'s (ELMD) stock forecast for 2027?
Based on our analysis of 3 Wall Street analysts, Electromed Inc. (ELMD) has a median price target of $40.00. The highest price target is $45.00 and the lowest is $36.00.
Is ELMD stock a good investment in 2027?
According to current analyst ratings, ELMD has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $42.10. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ELMD stock?
Wall Street analysts predict ELMD stock could reach $40.00 in the next 12 months. This represents a -5.0% decrease from the current price of $42.10. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Electromed Inc.'s business model?
The company generates revenue by designing, manufacturing, and distributing innovative medical devices that focus on respiratory therapy solutions. It primarily sells products like the SmartVest Airway Clearance System to healthcare providers and patients, targeting individuals with chronic respiratory conditions such as cystic fibrosis and bronchiectasis.
What is the highest forecasted price for ELMD Electromed Inc.?
The highest price target for ELMD is $45.00 from at , which represents a 6.9% increase from the current price of $42.10.
What is the lowest forecasted price for ELMD Electromed Inc.?
The lowest price target for ELMD is $36.00 from Benjamin Haynor at Lake Street, which represents a -14.5% decrease from the current price of $42.10.
What is the overall ELMD consensus from analysts for Electromed Inc.?
The overall analyst consensus for ELMD is bullish. Out of 3 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $40.00.
How accurate are ELMD stock price projections?
Stock price projections, including those for Electromed Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 2:22 AM UTC